CDI Bioscience
Madison · Founded 2007
About CDI Bioscience
CDI Bioscience has developed an innovative technology for increased yield of bioproducts, manufactured in cellular systems. Genetic engineering technology is used to control the metabolism of cells, thus shifting the cell from replicative to production mode (RP Shift®). In particular, this technology has been designed for use in mammalian cells, unlocking their potential to produce proteins, peptides and enzymes. The current design of the technology can be readily translated to bacterial and yeast cellular systems for the production of commercial grade bioproducts.
Company Facts
- Founded: 2007
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.0M
- Last round: Series Unknown (Dec 2007)
- Website: cdibiotech.com
- Phone: +1 (608)310-9575
Industries & Categories
Biopharma, Biotechnology, Genetics
Canonical: https://fsome.com/organization/cdi-bioscience-1522068 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.